Application Note

A Smart Solution To Clinical Supply Management

Source: PCI Pharma Services

By Carolyn Timpany, Senior Supplies Manager - International, Lisa Spence, Director, Clinical Supply Chain - International, Ed Groleau, Director, Clinical Supply Chain, North America, PCI Pharma Services

GettyImages-1327568875-technology-clinical trials-computer-medicine-research

With the number of registered clinical trials increasing significantly each year, it’s not surprising to learn that the clinical trials supply and logistics market is predicted to grow exponentially in the years ahead. Recent data suggests that by 2030 this market will be valued at approximately $12.4 billion, up from $5.1 billion in 2020; this translates to a Compound Annual Growth Rate (CAGR) of 9.1% from 2021 to 2030.1 Such growth places huge pressure on drug discovery companies, CROs and CDMOs to find supply management solutions which ensure seamless, efficient delivery of clinical trial materials worldwide, whilst navigating the challenges of more complex study designs and the ever-evolving regulatory landscape. PCI Pharma Services’ clinicalSMART™ is one such solution.

In this application note, two case studies demonstrate how a clinicalSMART™ Clinical Supply Manager (CSM) provided supply study oversight and managed unblinded IRT activities and drug inventory.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader